Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China · Delayed Price · Currency is CNY 38.17
+1.81 (4.98%)
Aug 4, 2026, 3:00 PM CST
Hangzhou Biotest Biotech Market Cap
Hangzhou Biotest Biotech has a market cap or net worth of 5.32 billion as of August 4, 2026. Its market cap has increased by 13.17% in one year.
Market Cap
5.32B
Enterprise Value
3.92B
Revenue
449.50M
Ranking
n/a
PE Ratio
173.85
Stock Price
38.17
ChartMarket Cap Chart
Since September 8, 2021, Hangzhou Biotest Biotech's market cap has decreased from 8.23B to 5.32B, a decrease of -35.33%. That is a compound annual growth rate of -8.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 5.32B | -3.76% |
| Dec 31, 2025 | 5.53B | 60.13% |
| Dec 31, 2024 | 3.45B | 6.92% |
| Dec 29, 2023 | 3.23B | -34.48% |
| Dec 30, 2022 | 4.93B | -33.91% |
| Dec 31, 2021 | 7.46B | -9.37% |
| Sep 8, 2021 | 8.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wuhan Keqian Biology Co.,Ltd | 6.02B |
| Chengdu Kanghua Biological Products | 6.00B |
| Jiangsu Aidea Pharmaceutical Group | 5.55B |
| Youcare Pharmaceutical Group | 5.42B |
| Novogene | 5.23B |
| Suzhou Fengbei Biotech Stock | 4.84B |
| Shouyao Holdings (Beijing) Co., LTD. | 4.73B |
| Beijing Konruns Pharmaceutical | 4.70B |